icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the target population of AFINITOR, in combination with exemestane, in the treatment of advanced breast cancer in postmenopausal women in line with article R-163-19 of the French Social Security Code.
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
amU1uB8K1dACG5zZ
Listen
